322 related articles for article (PubMed ID: 30639077)
1. Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort study.
Pruetarat N; Netbaramee W; Pattharathitikul S; Veeravigrom M
Brain Dev; 2019 May; 41(5):436-442. PubMed ID: 30639077
[TBL] [Abstract][Full Text] [Related]
2. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
4. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.
Ho AC; Chan SH; Chan E; Wong SS; Fung ST; Cherk SW; Fung EL; Ma KH; Tsui KW; Yau EK; Wong VC
Brain Dev; 2018 Jun; 40(6):473-479. PubMed ID: 29599011
[TBL] [Abstract][Full Text] [Related]
5. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of anti
Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
8. Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis.
Zekeridou A; Karantoni E; Viaccoz A; Ducray F; Gitiaux C; Villega F; Deiva K; Rogemond V; Mathias E; Picard G; Tardieu M; Antoine JC; Delattre JY; Honnorat J
J Neurol; 2015 Aug; 262(8):1859-66. PubMed ID: 25987208
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features, Therapeutic Response, and Follow-Up in Pediatric Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Experience from a Tertiary Care University Hospital in India.
Nagappa M; Bindu PS; Mahadevan A; Sinha S; Mathuranath PS; Taly AB
Neuropediatrics; 2016 Jan; 47(1):24-32. PubMed ID: 26727295
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
[TBL] [Abstract][Full Text] [Related]
11. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Outcomes of Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Infants and Toddlers.
Ren C; Zhang W; Ren X; Li J; Ding C; Wang X; Ren H; Fang F
Pediatr Neurol; 2021 Jun; 119():27-33. PubMed ID: 33838580
[TBL] [Abstract][Full Text] [Related]
13. Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Iizuka T; Kaneko J; Tominaga N; Someko H; Nakamura M; Ishima D; Kitamura E; Masuda R; Oguni E; Yanagisawa T; Kanazawa N; Dalmau J; Nishiyama K
JAMA Neurol; 2016 Jun; 73(6):706-13. PubMed ID: 27111481
[TBL] [Abstract][Full Text] [Related]
14. Heterogenous treatment for anti-NMDAR encephalitis in children leads to different outcomes 6-12 months after diagnosis.
Sakpichaisakul K; Patibat L; Wechapinan T; Sri-Udomkajrorn S; Apiwattanakul M; Suwannachote S
J Neuroimmunol; 2018 Nov; 324():119-125. PubMed ID: 30269038
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
16. The clinical features, treatment and outcomes of 33 children from Northwestern China with Anti-N-methyl-D-aspartate receptor encephalitis.
Dou X; Li D; Wu F; Wang Z; Niu M; Wu Y; Deng T; Wang D; Li X
Neurol Res; 2022 May; 44(5):429-438. PubMed ID: 34806564
[TBL] [Abstract][Full Text] [Related]
17. Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.
Li X; Hou C; Wu WL; Liang H; Zheng K; Zhang Y; Zeng Y; Chen L; Zhu H; Tian Y; Gao Y; Peng B; Yang S; Wang X; Ning S; Liao Y; Lin H; Chen WX
J Neuroimmunol; 2021 Mar; 352():577479. PubMed ID: 33486307
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of pediatric Anti-NMDA receptor encephalitis.
Shim Y; Kim SY; Kim H; Hwang H; Chae JH; Choi J; Kim KJ; Yum MS; Ko TS; Kim YO; Byeon JH; Lee J; Lee J; Kim JS; Lim BC
Eur J Paediatr Neurol; 2020 Nov; 29():87-91. PubMed ID: 33046392
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis.
Zhang M; Li W; Zhou S; Zhou Y; Yang H; Yu L; Wang J; Wang Y; Zhang L
Front Neurol; 2019; 10():596. PubMed ID: 31244759
[No Abstract] [Full Text] [Related]
20. [Efficacy and safety of cyclophosphamide as a sequential immunotherapy drug for anti-N-methyl-D-aspartate receptor encephalitis in children].
Zhu WW; Liao WP; Yi YH; Song XW
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jun; 19(6):668-671. PubMed ID: 28606234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
